Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Baxter International | BAX | May 31, 2024 | 34.09 | +1.97 |
Becton, Dickinson And Co | BDX | May 31, 2024 | 231.97 | +2.29 |
Berkshire Hathaway B | BRK-B | May 31, 2024 | 414.40 | +1.42 |
Best Buy | BBY | May 31, 2024 | 84.82 | +4.01 |
Bio-Rad Laboratories A | BIO | May 31, 2024 | 286.86 | +1.72 |
Bio-Techne | TECH | May 31, 2024 | 77.19 | -0.08 |
Biogen | BIIB | May 31, 2024 | 224.94 | +2.21 |
BlackRock | BLK | May 31, 2024 | 772.03 | +1.33 |
Blackstone | BX | May 31, 2024 | 120.50 | +0.98 |
Boeing | BA | May 31, 2024 | 177.61 | +2.81 |
Booking | BKNG | May 31, 2024 | 3 776.35 | +0.58 |
BorgWarner | BWA | May 31, 2024 | 35.66 | +1.25 |
Boston Properties | BXP | May 31, 2024 | 60.67 | +4.26 |
Boston Scientific | BSX | May 31, 2024 | 75.57 | +0.76 |
Bristol-Myers Squibb | BMY | May 31, 2024 | 41.09 | +2.09 |
Broadcom | AVGO | May 31, 2024 | 1 328.55 | -2.60 |
Broadridge Financial Solutions | BR | May 31, 2024 | 200.77 | +2.59 |
Brown & Brown | BRO | May 31, 2024 | 89.51 | +2.01 |
Brown Forman B | BF-B | May 31, 2024 | 45.86 | +3.59 |
Builders Firstsource | BLDR | May 31, 2024 | 160.79 | +0.39 |
Bunge | BG | May 31, 2024 | 107.59 | +2.33 |
C.H. Robinson Worldwide | CHRW | May 31, 2024 | 86.37 | +1.74 |
Cadence Design Systems | CDNS | May 31, 2024 | 286.31 | -0.67 |
Caesars Entertainment | CZR | May 31, 2024 | 35.56 | +11.65 |
Camden Property Trust | CPT | May 31, 2024 | 102.65 | +1.62 |
Campbell Soup | CPB | May 31, 2024 | 44.38 | +1.84 |
Capital One Financial | COF | May 31, 2024 | 137.63 | +1.06 |
Cardinal Health | CAH | May 31, 2024 | 99.27 | +1.60 |
CarMax | KMX | May 31, 2024 | 70.26 | +0.88 |
Carnival | CCL | May 31, 2024 | 15.08 | -0.79 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.